Reza Jarrahy, MD
Plastic and Reconstructive Surgery · Los Angeles, CANPI 1407956816
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,018 of the $10,120 with a category attached, or 79.2%. Medical Device Business Services, Inc. accounts for 74.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $7,593 and has fallen 97.4% since, to $200 in 2025.
Across 16 payments — averaging $632.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$8K
- Kls-martin L.p.$1K
- Axogen$952
- Biocomposites Inc$167
- TELA Bio, Inc.$167
- Dilon Technologies, Inc.$163
- plus $48 from 1 others
What the payments were for
- Travel & lodging$8,01879%
- Food & beverage$2,10221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $7,500 |
| Kls-martin L.p. | 9 | $1,124 |
| Axogen | 2 | $952 |
| Biocomposites Inc | 1 | $167 |
| TELA Bio, Inc. | 1 | $167 |
| Dilon Technologies, Inc. | 1 | $163 |
| Mentor Worldwide LLC | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,120 in reported general payments places this provider in the 80th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Los Angeles
- David KulberLos Angeles$194K
- Jeffrey HammoudehLos Angeles$159K
- Steven AgafonoffLos Angeles$14K
- Justine LeeLos Angeles$13K
- Dan YaminiLos Angeles$11K
- Nicholas DoLos Angeles$10K
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.